CD274 and invasive breast carcinoma: Our analysis revealed that there was a significant positive association between TUBA1C and CD274 in several cancer types, including KIRC, kidney renal papillary cell carcinoma (KIRP), stomach adenocarcinoma (STAD), and breast invasive carcinoma (BRCA), among others (Figure 4A).